Navigation Links
'Smart bomb' nanoparticle strategy impacts metastasis
Date:7/7/2008

A new treatment strategy using molecular "smart bombs" to target metastasis with anti-cancer drugs leads to good results using significantly lower doses of toxic chemotherapy, with less collateral damage to surrounding tissue, according to a collaborative team of researchers at the University of California, San Diego. By designing a "nanoparticle" drug delivery system, the UC San Diego team, led by Moores UCSD Cancer Center Director of Translational Research David Cheresh, Ph.D., has identified a way to target chemotherapy to achieve a profound impact on metastasis in pancreatic and kidney cancer in mice.

In a study to be published online the week of July 7 in advance of publication in the Proceedings of the National Academy of Sciences (PNAS), Cheresh, professor and vice chair of pathology, and members of his team report that the nanoparticle carrying a payload of chemotherapy homes in on a protein marker called integrin ανβ3 found on the surface of certain tumor blood vessels where it is associated with development of new blood vessels and malignant tumor growth.

The team found that the nanoparticle/drug combination didn't have much impact on primary tumors, but stopped pancreatic and kidney cancers from metastasizing throughout the bodies of mice. They showed that a greatly reduced dosage of chemotherapy can achieve the desired effect because the drug selectively targets the specific blood vessels that feed the cancerous lesion and kills the lesion without destroying surrounding tissue. The destruction of healthy tissue is a side-effect when chemotherapy is administered systemically, flooding the body with cancer-killing toxins.

"We were able to establish the desired anti-cancer effect while delivering the drug at levels 15 times below what is needed when the drug is used systemically," said Cheresh. "Even more interesting is that the metastatic lesions were more sensitive to this therapy than the primary tumor."

The study is an example of an initiative that joins researchers from UC San Diego's Health Sciences and the Jacobs School of Engineering to improve health care through innovative technologies. Engineers and oncologists working together designed a nanoparticle a microscopic-sized particle of 100 nanometers, made of various lipid-based polymers which delivers the cancer cell-killing drug doxorubicin to the network of blood vessels supporting the tumor that express the ανβ3 protein.

"Doxorubicin is known to be an effective anti-cancer drug, but has been difficult to give patients an adequate dose without negative side effects," Cheresh said. "This new strategy represents the first time we've seen such an impact on metastatic growth, and it was accomplished without the collateral damage of weight loss or other outward signs of toxicity in the patient."

Cancer metastasis is traditionally much more difficult to treat than the primary tumor, and is what usually leads to the patient's death. Because metastasis is more reliant on new blood vessel growth, or angiogenesis, than established tumors are, Cheresh theorized that targeting the anti-cancer drug to the sites of new blood vessel growth has a preferential effect on metastatic lesions.

"Traditional cancer therapies are often limited, or non-effective over time because the toxic side effects limit the dose we can safely deliver to the patient," said Cheresh. "This new drug delivery system offers an important advance in treating metastatic disease."


'/>"/>

Contact: Debra Kain
ddkain@ucsd.edu
619-543-6163
University of California - San Diego
Source:Eurekalert

Related medicine news :

1. New Smart Technology Makes Patient Data Collection Easier, More Efficient
2. New Survey Shows Americans are Still Concerned About Food Safety, Yet Still Not Smart About What They Like to Eat
3. Delta Dental of Illinois Introduces Smile Smart For Your Health
4. Toddler Study Proves Humans Outsmart Apes
5. SMART Association Becomes Healthcare Council Member of Smart Card Alliance
6. Smart insulin nanostructures pass feasibility test, UT study reports
7. New Oral-B(R) Triumph(TM) With SmartGuide(TM) is the First Power Toothbrush With a Wireless Display
8. Pasta Gets Smarter - and Healthier
9. Healthy Living Made Easy with New Diabetes Foodsmart e-Newsletter
10. Oridion Introduces New Smart Capnography System for Improved Patient Safety
11. SafeSmart, Inc. Presents SafetyTies to Sixth Annual MedAssets Technology Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... ... January 17, 2017 , ... Anesthesia Progress – ... to choose the best drug option for each patient. Dentists have several general anesthesia ... overall outcomes. , Researchers from the Tokyo Dental College in Tokyo, Japan wanted to ...
(Date:1/17/2017)... AZ (PRWEB) , ... January 17, 2017 , ... ... and improved supplement, Healthful-Flex. , The company, owned and operated by Ed ... public at a reasonable price with the highest level of customer service. Healthful ...
(Date:1/17/2017)... ... January 17, 2017 , ... Achieve TMS West, with ... a new office in San Clemente, California this month. Achieve TMS West is ... successfully treating individuals struggling with major depression. Depression impacts over 15 million adults ...
(Date:1/17/2017)... CA (PRWEB) , ... January 17, 2017 , ... A ... named winners of the fourth Cradle to Cradle Product Design Challenge , the ... fourth in a series of six circular design challenges scheduled to run through early ...
(Date:1/17/2017)... Gatos, CA (PRWEB) , ... January 17, 2017 , ... ... announced the results of a double blind clinical study for its dental gel that ... a leading national brand of toothpaste containing triclosan. The study was conducted at the ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... SCOTTSDALE, Ariz. , Jan. 17, 2017 ... retired US Navy Capt. Mark Kelly as ... (ACMA) 2017 National Conference in Washington D.C. ... shuttle commander, will speak on Friday morning, April 21 ... management professionals from across the country are expected to ...
(Date:1/17/2017)... Jan. 17, 2017  Market Research Future published a Half Cooked ... is expected to reach USD 33.6 million during the period 2016 ... Highlights ... Endoscopy Devices Market has been examined as a swiftly growing market ... huge demand for endoscopy device in various regions.  The increasing growth ...
(Date:1/17/2017)... NEW YORK , Jan. 17, 2016  Attorney Advertising ... on behalf of purchasers of Anthera Pharmaceuticals, Inc. ("Anthera" or ... encouraged to obtain additional information and assist the investigation by ... investigation concerns whether Anthera and certain of its officers and/or ... Exchange Act of 1934. ...
Breaking Medicine Technology: